Literature DB >> 10950681

Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.

B Pötzsch, W P Klövekorn, K Madlener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10950681     DOI： 10.1056/NEJM200008173430718

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Heparin "hitts" again.

Authors:  Federico Goti; Wolfgang Korte; Duri Gianom; Marco Decurtins
Journal:  Eur J Clin Pharmacol       Date:  2002-02       Impact factor: 2.953

Review 2.  Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors:  Albrecht Leo; Susanne Winteroll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

3.  Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.

Authors:  Christian Schreiber; W Dietrich; S Braun; M Kostolny; A Eicken; R Lange
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

Review 4.  Thrombin inhibitors and cardiopulmonary bypass.

Authors:  Alan Merry
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 5.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03

Review 7.  Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

Authors:  E Marc Jolicoeur; Tracy Wang; Renato D Lopes; E Magnus Ohman
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

8.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

Review 9.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

Review 10.  Immune pathogenesis of heparin-induced thrombocytopenia.

Authors:  Sanjay Khandelwal; Gowthami M Arepally
Journal:  Thromb Haemost       Date:  2016-07-28       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.